Skip to main content
. 2020 May 8;7(5):e16342. doi: 10.2196/16342

Table 3.

Summary statistics on outcomes by condition, time phase, and assessment time points.

Outcomes, time phase, and assessment time points Active-AtBMa + active-ApBMb Active-AtBM + sham-ApBM Sham-AtBM + active-ApBM Sham-AtBM + sham-ApBM
PPAc, n1/n2 (%)d


Baseline 0/105 (0) 0/132 (0) 0/137 (0) 0/130 (0)


IAe1 11/79 (14) 16/111 (14.4) 5/110 (4.5) 8/94 (9)


IA2 7/51 (14) 9/70 (13) 5/75 (7) 11/61 (18)


IA3 7/34 (21) 6/39 (15) 6/54 (11) 9/49 (18)


IA4 5/28 (18) 6/33 (18) 7/43 (16) 5/34 (15)


IA5 8/23 (35) 4/27 (15) 8/33 (24) 3/26 (12)


Midf 7/21 (33) 2/24 (8) 6/27 (22) 3/20 (15)

TP1g 45/341 (13.2) 43/436 (9.9) 37/479 (7.7) 39/414 (9.4)


IA6 8/19 (42) 4/21 (19) 5/24 (21) 2/20 (10)


IA7 7/17 (41) 2/19 (11) 4/20 (20) 3/19 (16)


IA8 6/17 (35) 3/17 (18) 2/19 (11) 3/19 (16)


IA9 5/15 (33) 2/14 (14) 3/15 (20) 3/17 (18)


IA10 5/14 (36) 2/13 (15) 3/12 (25) 2/15 (13)


Posth 5/14 (36) 2/11 (18) 3/10 (30) 4/15 (27)

TP2i 36/96 (38) 15/95 (16) 20/100 (20.0) 17/105 (16.2)


IA11 5/13 (38) 2/11 (18) 3/10 (30) 4/15 (27)


FU1j 5/13 (39) 3/11 (27) 3/10 (30) 1/14 (7)


FU2k 3/12 (25) 3/11 (27) 3/9 (33) 1/13 (8)


FU3l 4/12 (33) 2/9 (22) 3/9 (33) 2/12 (17)

TP3m 17/50 (34) 10/42 (24) 12/38 (32) 8/54 (15)
DCUn, mean (SD)o

TP1 (baseline) 15.25 (9.70) 16.71 (9.97) 15.43 (8.48) 15.20 (8.44)


IA1 11.23 (8.60) 12.96 (10.58) 12.89 (8.22) 13.48 (8.98)


IA2 11.07 (9.11) 13.07 (10.12) 12.48 (8.63) 10.97 (9.76)


IA3 10.41 (9.99) 13.30 (10.48) 11.96 (9.23) 9.74 (8.46)


IA4 10.06 (10.71) 13.15 (11.09) 11.39 (9.93) 11.36 (8.93)


IA5 9.26 (9.54) 14.15 (11.30) 11.58 (10.73) 9.24 (8.28)


Mid 7.77 (10.25) 15.14 (9.94) 12.52 (10.94) 11.55 (11.36)

TP2 10.44 (9.38) 13.33 (10.47) 12.31 (9.13) 11.52 (9.23)


IA6 6.79 (9.27) 14.71 (10.37) 13.15 (11.74) 10.33 (9.68)


IA7 7.84 (10.36) 15.13 (9.60) 13.70 (11.71) 10.62 (9.94)


IA8 8.49 (10.37) 15.15 (10.74) 13.15 (12.25) 10.19 (10.22)


IA9 8.56 (10.21) 15.24 (11.53) 12.10 (11.63) 8.68 (7.59)


IA10 10.16 (10.65) 14.53 (10.03) 11.48 (10.75) 7.14 (6.99)


Post 8.67 (10.45) 14.63 (10.79) 9.22 (8.93) 7.48 (7.72)

TP3 8.32 (9.97) 14.92 (10.19) 12.51 (11.25) 9.22 (8.81)


IA11 10.56 (12.26) 14.07 (10.98) 9.15 (8.10) 7.00 (7.25)


FU1 11.70 (16.09) 15.77 (14.69) 7.99 (8.53) 6.55 (6.19)


FU2 12.21 (14.00) 13.42 (14.98) 8.27 (9.78) 8.23 (6.20)


FU3 12.29 (13.19) 15.68 (18.99) 8.83 (9.05) 8.70 (7.23)

TP4p 11.67 (13.55) 14.69 (14.43) 8.56 (8.50) 7.56 (6.60)
AtBq, mean (SD)o

TP1 (baseline) 24.15 (30.69) 27.42 (27.65) 24.84 (27.36) 24.56 (29.79)


IA1 23.06 (37.74) 16.36 (36.17) 27.27 (40.80) 23.95 (28.87)


IA2 15.32 (42.95) 15.92 (32.99) 18.10 (35.52) 15.85 (31.78)


IA3 15.42 (32.93) 5.62 (46.13) 19.84 (37.84) 21.73 (39.93)


IA4 6.89 (33.65) −2.38 (32.61) 20.40 (43.01) 23.65 (35.33)


IA5 −0.88 (20.32) −1.86 (32.68) 8.92 (53.41) 14.02 (30.31)


Mid 3.40 (33.38) 8.35 (25.93) 3.29 (25.17) 16.45 (18.61)

TP2 14.05 (36.44) 10.00 (36.04) 19.39 (40.38) 20.20 (31.98)


IA6 15.21 (29.28) 9.78 (34.79) 12.41 (40.02) 14.28 (24.70)


IA7 11.24 (26.26) 0.92 (28.94) 4.65 (31.91) 16.16 (28.66)


IA8 14.24 (32.64) 5.44 (31.32) 5.64 (34.85) 9.17 (29.67)


IA9 4.33 (43.25) 4.89 (27.51) 5.50 (31.64) 8.32 (30.34)


IA10 4.71 (33.25) −2.00 (32.02) −4.42 (42.26) 8.50 (17.07)


Post −4.08 (12.82) −2.46 (28.18) 10.70 (25.76) 2.47 (26.12)

TP3 8.42 (30.96) 3.35 (30.33) 6.23 (34.72) 10.23 (26.39)


IA11 1.19 (32.46) −16.59 (23.64) −2.15 (25.38) 5.67 (33.41)


FU3 7.36 (14.38) 2.28 (16.09) 4.25 (23.70) 8.96 (17.65)

TP4 4.02 (25.49) 8.10 (22.27) 0.69 (24.14) 7.13 (27.12)
ApBr, mean (SD)o

TP1 (baseline) 7.84 (65.28) 8.82 (84.61) 4.52 (67.04) 9.70 (77.34)


IA1 4.88 (77.67) −11.23 (114.00) 11.25 (113.95) 4.66 (98.25)


IA2 7.10 (76.98) −7.74 (71.96) −0.17 (78.86) 9.56 (82.04)


IA3 1.15 (73.75) −4.47 (46.16) −1.83 (82.75) 12.24 (59.45)


IA4 −35.76 (42.72) 12.82 (70.46) 10.87 (75.61) 9.80 (71.82)


IA5 −2.50 (73.86) −13.05 (53.32) 0.79 (62.30) −7.06 (68.51)


Mid 7.85 (47.22) −6.87 (27.64) −10.35 (91.38) 11.30 (48.89)

TP2 0.50 (71.27) 6.47 (81.99) 3.72 (90.65) 7.04 (79.30)


IA6 −12.18 (56.42) 8.10 (54.18) −26.52 (99.34) 4.58 (41.78)


IA7 −10.68 (44.52) 18.58 (47.19) −3.10 (67.67) 3.97 (99.19)


IA8 6.94 (49.90) −2.09 (49.79) 26.66 (82.69) 8.47 (47.50)


IA9 −7.70 (78.92) −1.46 (42.34) −5.10 (31.09) −3.12 (62.89)


IA10 −22.75 (38.49) 20.50 (45.27) −21.67 (39.40) −9.87 (53.18)


Post −17.96 (35.54) 26.58 (32.70) −5.60 (36.41) −13.10 (29.10)

TP3 10.13 (52.45) 10.99 (46.77) 5.42 (71.26) 0.75 (59.90)


IA11 −14.96 (52.63) 20.36 (51.52) −15.70 (22.51) 34.20 (66.24)


FU3 2.27 (41.97) −4.39 (41.06) 2.06 (54.69) −12.04 (59.54)

TP4 7.06 (47.83) 9.22 (47.61) 7.81 (39.78) 13.65 (66.41)

aAtBM: attentional bias modification.

bApBM: approach bias modification.

cPPA: point prevalence abstinence.

dFor PPA at each assessment time point, n1/n2= number of participants coded as 1 (that is, quit) at that assessment time point divided by the total number of participants who reported their smoking status at that assessment time point; at each time phase, n1/n2= sum of observations coded as 1 (that is, quit) at that time phase divided by sum of all reported observations at that time phase.

eIA: interim assessment.

fMid: midtraining assessment.

gTP1: time phase 1, first half intervention phase for PPA; baseline for DCU, AtB, and ApB.

hPost: posttraining assessment.

iTP2: time phase 2, second half intervention phase for PPA, first half intervention phase for DCU, AtB, and ApB.

jFU1: follow-up assessment at 1 month.

kFU2: follow-up assessment at 2 months.

lFU3: follow-up assessment at 3 months.

mTP3: time phase 3, follow-up phase for PPA; second half intervention phase for DCU, AtB, and ApB.

nDCU: daily cigarette use.

oFor DCU, AtB, and ApB, at each assessment time point, average score at the assessment time point is reported; at each time phase, time average score at that time phase is reported.

pTP4: time phase 4, follow-up phase for DCU, AtB, and ApB.

qAtB: attentional bias for smoking stimuli.

rApB: approach bias for smoking stimuli.